相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation
Meng-Zhu Shen et al.
Therapeutic Advances in Hematology (2022)
The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study
Sanjoy K. Paul et al.
EUROPEAN HEART JOURNAL (2021)
Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group
Lan-Ping Xu et al.
BONE MARROW TRANSPLANTATION (2021)
The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study
Sanjoy K. Paul et al.
EUROPEAN HEART JOURNAL (2021)
Basiliximab as Treatment for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients after Haploidentical Hematopoietic Stem Cell Transplantation
Fei-Fei Tang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Prognostic factors and long-term follow-up of basiliximab for steroid-refractory acute graft-versus-host disease: Updated experience from a large-scale study
Si-Ning Liu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial
Madan Jagasia et al.
BLOOD (2020)
Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
Florent Malard et al.
LEUKEMIA (2020)
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease
Tomomi Toubai et al.
BLOOD (2020)
Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation
Sameem Abedin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Occurrence and Severity of Donor Lymphocyte Infusion-Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
Wen-Jing Yu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
Helene M. Schoemans et al.
BONE MARROW TRANSPLANTATION (2018)
A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD
Gerard Socie et al.
BLOOD (2017)
Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease
I. Garcia-Cadenas et al.
BONE MARROW TRANSPLANTATION (2017)
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The use of basiliximab-infliximab combination for the treatment of severe gastrointestinal acute GvHD
M. Nadeau et al.
BONE MARROW TRANSPLANTATION (2016)
Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody
Geothy Chakupurakal et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
Andrew C. Harris et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease
Lenneke F. J. van Groningen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis
Shahrukh Hashmi et al.
LANCET HAEMATOLOGY (2016)
A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality
Margaret L. MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan H. Jagasia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
Joanne Kurtzberg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Basiliximab: efficacy and safety evaluation in kidney transplantation
Claudio Ponticelli
EXPERT OPINION ON DRUG SAFETY (2014)
Long-term follow-up of corticosteroid refractory acute GVHD treated with an Inolimomab-based algorithm: a single center experience
S. Girerd et al.
BONE MARROW TRANSPLANTATION (2013)
The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
Jacques Galipeau
CYTOTHERAPY (2013)
Treatment and management of graft-versus-host disease: improving response and survival
Catherine Garnett et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
Paul J. Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Diagnosis and management of acute graft-versus-host disease
Fiona L. Dignan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibility
Y. Wang et al.
BONE MARROW TRANSPLANTATION (2011)
Basiliximab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease After Unmanipulated HLA-Mismatched/Haploidentical Hematopoietic Stem Cell Transplantation
J. Z. Wang et al.
TRANSPLANTATION PROCEEDINGS (2011)
Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Joseph Pidala et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience
M. Miano et al.
BONE MARROW TRANSPLANTATION (2009)
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD
T. Furlong et al.
BONE MARROW TRANSPLANTATION (2009)
Innovative approaches to treat steroid-resistant or steroid refractory GVHD
M. Berger et al.
BONE MARROW TRANSPLANTATION (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children
J. Inagaki et al.
BONE MARROW TRANSPLANTATION (2008)
Long-term follow-up of patients treated with daclizumab for steroid-refractoryacute graft-vs-host disease
M-A Perales et al.
BONE MARROW TRANSPLANTATION (2007)
Treatment of acute graft-versus-host disease with prednisolone:: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin
Maria Teresa Van Lint et al.
BLOOD (2006)
Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist
VAM Funke et al.
BONE MARROW TRANSPLANTATION (2006)
Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion
D Porter et al.
SEMINARS IN HEMATOLOGY (2006)
Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time
A Gratwohl et al.
BONE MARROW TRANSPLANTATION (2005)
Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
M Krejci et al.
ANNALS OF HEMATOLOGY (2005)
Efficacy of the interleukin-2 receptor antagonist basiliximab in steroid-refractory acute graft-versus-host disease
M Schmidt-Hieber et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
XJ Huang et al.
BONE MARROW TRANSPLANTATION (2005)
Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept
D Wolff et al.
BONE MARROW TRANSPLANTATION (2005)
Hepatitic graft-versus-host disease after hematopoietic stem cell transplantation: Clinicopathologic features and prognostic implication
SY Ma et al.
TRANSPLANTATION (2004)
Tumor necrosis factor-α blockade for the treatment of acute GVHD
D Couriel et al.
BLOOD (2004)
Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant
JG Kim et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
G Massenkeil et al.
BONE MARROW TRANSPLANTATION (2002)
Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion
G Akpek et al.
BLOOD (2002)
Early Antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease
ML MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment
S Arai et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Graft-versus-host disease - Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin
H Khoury et al.
BONE MARROW TRANSPLANTATION (2001)
分享论文
